• A. P. Oranje
  • D. Van Gysel


Mastocytosis covers a wide spectrum of a proliferative diseases of mast cells in the skin and/or in internal organs. We recognize different subtypes of mastocytosis: (a) mastocytoma, (b) urticaria pigmentosa, (c) diffuse cutaneous mastocytosis, (d) telangiectasia macularis eruptiva perstans (TMEP), (e) systemic mastocytosis and (f) mast cell leukemia. The most common manifestation of mastocytosis is urticaria pigmentosa, which is characterized by small or larger brown-red maculopapules on the skin. Skin is the organ mostly or only involved, but occasionally other organs are also infiltrated. In particular, as a second organ, the bones maybe involved.


Mast Cell Bullous Pemphigoid Epidermolysis Bullosa Systemic Mastocytosis Disodium Cromoglycate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Kettelhut BV, Metcalfe DD (1991) Pediatric mastocytosis. J Invest Dermatol 96 [Suppl]: 15–18CrossRefGoogle Scholar
  2. 2.
    Fowler JF, Parsley WM, Cotter PG (1986) Familial urticaria pigmentosa. Arch Dermatol 122: 80–81PubMedCrossRefGoogle Scholar
  3. 3.
    Van Gysel D, Oranje AP (1998) Mastocytosis. In: Harper J, Oranje AP, Prose N (eds) Textbook of Paediatric Dermatology. Blackwell Science, London, (in press)Google Scholar
  4. 4.
    Oranje AP, Widowati S, Sukardi A et al (1991) Diffuse cutaneous mastocytosis mimicking staphylococcal scalded skin syndrome [report of three cases]. Pediatr Dermatol 8: 147–151PubMedCrossRefGoogle Scholar
  5. 5.
    Van Gysel D, Oranje AP, Vermeijden I, Lijster J de Raadt, Toorenenbergen van A (1996) Evaluation of urinary N-methylhistamine measurement in patients with mastocytosis. J Am Acad Dermatol 35: 556–558PubMedCrossRefGoogle Scholar
  6. 6.
    Czarnetzki BM, Behrend H (1981) Urticaria pigmentosa: clinical picture and response to oral disodium cromoglycate. Br J Dermatol 105: 563–567PubMedCrossRefGoogle Scholar
  7. 7.
    Czarnetzki BM (1983) A double-blind cross-over study of the effect of ketotifen in urticaria pigmentosa. Dermatologica 166: 44–47PubMedCrossRefGoogle Scholar
  8. 8.
    Kettelhut BV, Berkebile C, Bradley D, Metcalfe DD (1989) A double-blind, placebo-controlled, cross-over trial of ketotifen versus hydroxizine in the treatment of systemic mastocytosis. J All Clin Immunol 83: 866–870CrossRefGoogle Scholar
  9. 9.
    Guzzo C, Lavker R, Roberts J et al (1991) Urticaria pigmentosa: systemic evaluation and successful treatment with topical steroids. Arch Dermatol 127: 191–196PubMedCrossRefGoogle Scholar
  10. 10.
    Parris WCV, Scott HW, Smith BE (1986) Anesthetic management of systemic mastocytosis: experience with 42 cases. Anesth Analg 65: 117SGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2000

Authors and Affiliations

  • A. P. Oranje
  • D. Van Gysel

There are no affiliations available

Personalised recommendations